Related Experiment Video
Updated: Mar 2, 2026

A Modified Sonographic Algorithm for Image Acquisition in Life-Threatening Emergencies in the Critically Ill Newborn
Published on: April 7, 2023
Coming full circle: thirty years of paediatric fluid resuscitation
N J Glassford1, B Gelbart2, R Bellomo3
1Registrar and Clinical Research Fellow, Department of Intensive Care, Austin Hospital, PhD Candidate, Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Melbourne, Victoria.
Insights
Fluid bolus therapy (FBT) in septic children has limited evidence for benefit, prompting a review of current practices. Further research is needed to optimize FBT strategies and patient outcomes in pediatric intensive care.
Area of Science:
- Pediatric Critical Care Medicine
- Septic Shock Management
- Fluid Resuscitation Research
Background:
- Fluid bolus therapy (FBT) is a standard treatment for septic children.
- Evidence supporting liberal FBT in developed nations is limited.
- The FEAST trial influenced FBT guidelines, particularly in resource-poor settings.
Purpose of the Study:
- To evaluate the current evidence base for FBT in pediatric sepsis.
- To identify challenges and opportunities in conducting FBT research in critically ill children.
- To advocate for further investigation into optimal FBT strategies and alternatives.
Main Methods:
- Review of existing clinical research on FBT in pediatric sepsis.
- Analysis of the impact of the FEAST trial on clinical practice and guidelines.
- Discussion of modern clinical trial methodologies for critically ill pediatric populations.
Main Results:
- Limited evidence exists for the independent benefit of liberal FBT in developed countries.
- Fluid accumulation from FBT is associated with pulmonary pathology in children.
- Post-FEAST trials continue to explore liberal FBT despite potential risks.
Conclusions:
- There is a need for robust, powered trials examining FBT efficacy versus alternatives in pediatric emergency and ICU settings.
- Modern trial designs may overcome challenges in researching interventions for critically ill children.
- Re-evaluation of FBT is warranted due to its widespread use and potential for harm.
Abstract:
Fluid bolus therapy (FBT) is a cornerstone of the management of the septic child, but clinical research in this field is challenging to perform, and hard to interpret. The evidence base for independent benefit from liberal FBT in the developed world is limited, and the Fluid Expansion as Supportive Therapy (FEAST) trial has led to conservative changes in the World Health Organization-recommended approach to FBT in resource-poor settings. Trials in the intensive care unit (ICU) and emergency department settings post-FEAST have continued to explore liberal FBT strategies as the norm, despite a strong signal associating fluid accumulation with pulmonary pathology in the paediatric population. Modern clinical trial methodology may ameliorate the traditional challenges of performing randomised interventional trials in critically ill children. Such trials could examine differing strategies of fluid resuscitation, or compare early FBT to early vasoactive agent use. Given the ubiquity of FBT and the potential for harm, appropriately powered examinations of the efficacy of FBT compared to alternative interventions in the paediatric emergency and ICU settings in the developed world appear justified and warranted.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Dosing: Infants and Children
Cardiopulmonary Resuscitation I: Adult
Continuous Renal Replacement Therapy

